Peter J. J. Goadsby, MD, PhD

Neurology
NIHR-Wellcome Trust King's Clinical Research Facility, King’s College London; University of California, Los Angeles, CA
London, England, United Kingdom

Presentation(s):

• Poster Number-29 - Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial

  Poster Abstracts